Summary:
- This article discusses a biotech company called Moderna, which is developing a new type of vaccine technology using messenger RNA (mRNA).
- The article explains that Moderna's mRNA technology has the potential to revolutionize the way vaccines are developed and produced, as it allows for faster and more efficient vaccine development compared to traditional methods.
- The article also mentions that Moderna's stock price has been highly volatile, with investors viewing the company as a "biotech lottery ticket" due to the potential of its mRNA technology.